AAPL Downgraded: iPhone & Profit Concerns Hit Apple Stock
Apple (NASDAQ: AAPL) Downgraded to Underperform Amid iPhone and Profitability Concerns Jefferies downgraded Apple from Hold to Underperform and lowered its price target to…
Outlook Therapeutics (NASDAQ:OTLK) Sees Increased Price Target and Earnings Beat Expectations
Analysts have significantly raised the consensus price target for Outlook Therapeutics (NASDAQ:OTLK), reflecting growing confidence in the biopharmaceutical company. This positive shift is driven…
The Honest Company (NASDAQ:HNST) Reports Strong Q2 Earnings, Analyst Raises Price Target
The Honest Company (NASDAQ:HNST) exceeded Q2 earnings expectations, reporting $0.04 per share, double the consensus estimate. Morgan Stanley raised its price target for The…
Loma Negra (NYSE: LOMA) Navigates Mixed Market: Q2 2026 Results and Analyst Outlook
Loma Negra (NYSE: LOMA), a key player in the Argentine cement market, shows mixed financial performance with a significant market capitalization and recent stock…
Hikma Pharmaceuticals (HKMPF): Strong Ratings & Higher Targets
Hikma Pharmaceuticals PLC (OTC: HKMPF): Strong Analyst Ratings and Increased Price Targets Signal Positive Investment Outlook Hikma Pharmaceuticals PLC (OTC: HKMPF) received "Buy" ratings…
H&R Block (NYSE: HRB) Price Target Raised Amid Strong Financial Performance and Tech Growth
Analyst raises H&R Block (NYSE: HRB) stock price target to $60.00, indicating a potential 12.04% upside. The company reported strong Q4 fiscal 2026 results…
Aecom (NYSE: ACM) Stock Analysis: Price Target vs. Legal Challenges
UBS analyst sets a positive price target for Aecom (NYSE: ACM) stock, indicating potential upside. The company faces a securities fraud investigation following its…
JVA: Analyst Sets Bullish $10 Price Target Amidst Coffee Trends
Analyst Sets Bullish Price Target for Coffee Holding Co., Inc. (NASDAQ: JVA) Amidst Coffee Industry Trends An analyst has set a bullish $10.00 price…
Intuitive Surgical (NASDAQ:ISRG): Analyst Upgrades Amidst Valuation Shift in Robotic Surgery Market
Analyst Confidence Boost: Deutsche Bank upgraded Intuitive Surgical (NASDAQ:ISRG) from Sell to Buy, signaling renewed confidence despite a 33% stock plunge in 2026. Attractive…
Analyst Raises Price Target for Broadwind (NASDAQ: BWEN) Amid Strategic Shift
Roth Capital analyst Justin Clare has increased the price target for Broadwind (NASDAQ: BWEN) to $6.50, indicating a potential upside of 21.72%. The company…
Citigroup Reaffirms Outperform Rating for Excelerate Energy (NYSE: EE) Amid Strong Q2 Performance
Citigroup restated its "Outperform" rating for Excelerate Energy, highlighting confidence in the LNG solutions provider. Excelerate Energy reported strong Q2 2026 results, including a…
Merck & Co., Inc. (NYSE:MRK) Shows Strong Growth and Positive Analyst Outlook
Merck & Co., Inc. (NYSE:MRK) received an "Outperform" rating and a $143.00 price target from Daiwa, indicating a 9.62% potential upside. The pharmaceutical giant…
Corebridge Financial (NYSE: CRBG) Sees Price Target Hike Amid Strong Q2 Earnings and Strategic Moves
Analyst firm Piper Sandler increased its price target for Corebridge Financial, reflecting confidence in its future performance and maintaining an "Overweight" rating. Corebridge Financial…
Teva Pharmaceutical Industries (NYSE: TEVA) Stock Surges on Strategic Pivot to Specialty Drugs and Strong Analyst Outlook
Teva Pharmaceutical Industries is undergoing a significant strategic shift, moving from traditional generic drugs to a focus on specialty and innovative medicines. Analyst firm…
Novo Nordisk (NYSE: NVO) Stock Outlook: Navigating GLP-1 Competition and Price Target Adjustments
Novo Nordisk faces a "Sell" rating due to increasing competitive pressures and internal operational challenges. An analyst has set a cautious price target of…
Entegris (NASDAQ: ENTG) Stock Upgraded to Buy Amid Strong Q2 Earnings and AI Demand
Entegris (NASDAQ: ENTG) received an upgrade from Deutsche Bank to "Buy," signaling positive future performance. The company reported strong Q2 2026 results, with non-GAAP…
CAVA (NYSE: CAVA) Stock Analysis: Despite Price Target Adjustment, Strong Earnings and Revenue Drive Growth
Despite a lowered analyst price target, CAVA (NYSE: CAVA) demonstrates significant growth potential. The fast-casual Mediterranean restaurant chain reported strong Q2 2026 financial results,…
Marriott International (NASDAQ: MAR) Receives 'Outperform' Rating from CICC Amid Strong Q2 Financial Performance
CICC initiates an "Outperform" rating on Marriott International (NASDAQ: MAR), citing strong earnings drivers and a robust business model. The company reported strong Q2…
Amentum (NYSE:AMTM) Shows Resilience Amidst Revenue Miss and Analyst Price Target Adjustment
An analyst from Morgan Stanley (NYSE: MS) adjusted the price target for Amentum (NYSE:AMTM) to $24, indicating a potential upside of 7.00% from its…